Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
What Does The Current Evidence Say
TRIUMPH-4 represents Eli Lilly's first successful Phase 3 trial for Retatrutide, moving beyond the promising Phase 2 results from 2023 that showed 24% weight loss
Iritani S, Imai K, Takai K, et al
United Therapeutics Corporation has received FDA clearance to begin the first-ever human clinical trial of its investigational @UHeart xenotransplant, marking a groundbreaking step forward in organ transplantation innovation
Acknowledgements The authors thank Noel Saguil for assistance with field collections, Dylan Taylor for the images of C
US$ 29.25
US$ 21.53
US$ 24.99
US$ 25.68
US$ 26.49
US$ 20.34
